Havana, Cuba_ Almost 10 years after the treatment was first introduced into the country’s healthcare system, today over 65,000 Cubans nationwide have benefited from Heberprot-P, Granma newspaper publishes.

The medication, only treatment of its kind in the world, is designed to treat advanced stage diabetic foot ulcers, and reduce the risk of amputation in almost 80% of all cases.

Registered in over 20 nations, Heberprot-P has received the Gold Medal from the World Intellectual Property Organization.

Iris Lugo, communications specialist of the Center for Genetic Engineering and Biotechnology (CIGB), reported that Havana’s Riviera Hotel will host the 19th National Encounter on the Expansion of the Comprehensive Program to Treat Patients with Diabetic Foot Ulcers using Heberprot-P, May 11-12.

Organized by the Ministry of Public Health in collaboration with the CIGB, the event will see the participation of over 250 specialists in Angelology and Vascular Surgery who, among other topics, will review the performance and key results of the program.

Compartir / Share